Literature DB >> 20349240

Leg ulcers in the antiphospholipid syndrome may be considered as a form of pyoderma gangrenosum and they respond favorably to treatment with immunosuppression and anticoagulation.

Carlos A Cañas1, Carlos E Durán, Juan C Bravo, Dora E Castaño, Gabriel J Tobón.   

Abstract

Leg ulcers are a manifestation of antiphospholipid syndrome (APS), and characteristically respond poorly to treatment. Because the similar findings both clinical and pathological to pyoderma gangrenosum (PG), we treated these patients with a combination of immunosuppression (steroids, azathioprine or cyclosporine), acetylsalicylic acid and anticoagulation. We evaluated the response to the combined treatment with steroids, immunosuppression, acetylsalicylic acid, anticoagulation and local measures in patients with APS and leg ulcers resembling PG. We studied 8 women with leg ulcers of a cohort of 53 patients with APS (15%). Pathological findings of PG were observed in all patients. Seven patients (87.5%) received cyclosporine as usual for the treatment of PG, and all patients received steroids and anticoagulation with warfarin. Cicatrisation was present in all patients in 7 months. Leg ulcers in patients with APS may be resemble to PG, and their treatment with immunosuppression, acetylsalicylic acid and anticoagulation is effective for this severe and poorly responding condition.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20349240     DOI: 10.1007/s00296-010-1418-1

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  20 in total

1.  [Antiphospholipid antibodies and deep venous thrombosis in hemorrhagic rectocolitis disclosed by pyoderma gangrenosum].

Authors:  F Dupuis; A Petit; D Salaun; N Davous; M Sigal
Journal:  Presse Med       Date:  1996-06-29       Impact factor: 1.228

2.  Pyoderma gangrenosum and extensive caval thrombosis associated with the antiphospholipid syndrome--a case report.

Authors:  S Chacek; J MacGregor-Gooch; J Halabe-Cherem; H Nellen-Hummel; A Quiñones-Galvan
Journal:  Angiology       Date:  1998-02       Impact factor: 3.619

Review 3.  Pyoderma gangrenosum: classification and management.

Authors:  F C Powell; W P Su; H O Perry
Journal:  J Am Acad Dermatol       Date:  1996-03       Impact factor: 11.527

4.  Efficacy of human intravenous immune globulin in pyoderma gangrenosum.

Authors:  A K Gupta; N H Shear; D N Sauder
Journal:  J Am Acad Dermatol       Date:  1995-01       Impact factor: 11.527

Review 5.  Neutrophilic dermatoses.

Authors:  Jeffrey P Callen
Journal:  Dermatol Clin       Date:  2002-07       Impact factor: 3.478

6.  Successful therapy of refractory pyoderma gangrenosum and periorbital phlegmona with tacrolimus (FK506) in ulcerative colitis.

Authors:  Daniel C Baumgart; Bertram Wiedenmann; Axel U Dignass
Journal:  Inflamm Bowel Dis       Date:  2004-07       Impact factor: 5.325

7.  Pyoderma gangrenosum associated with the secondary antiphospholipid syndrome.

Authors:  M H Schmid; C Hary; B Marstaller; B Konz; C M Wendtner
Journal:  Eur J Dermatol       Date:  1998 Jan-Feb       Impact factor: 3.328

Review 8.  Pyoderma gangrenosum: clinical presentation and outcome in 18 cases and review of the literature.

Authors:  Dirk O Hasselmann; Guido Bens; Wolfgang Tilgen; Jörg Reichrath
Journal:  J Dtsch Dermatol Ges       Date:  2007-07       Impact factor: 5.584

Review 9.  Cutaneous ulceration resembling pyoderma gangrenosum in the primary antiphospholipid syndrome: a report of two additional cases and review of the literature.

Authors:  I H Schlesinger; G A Farber
Journal:  J La State Med Soc       Date:  1995-08

10.  Lupus and leg ulcers--a diagnostic quandary.

Authors:  Venkat Reddy; Magdalena Dziadzio; Shahir Hamdulay; Sara Boyce; Nidhi Prasad; Andrew Keat
Journal:  Clin Rheumatol       Date:  2007-07       Impact factor: 3.650

View more
  6 in total

1.  Leg ulcers in antiphospholipid syndrome secondary to systemic lupus erythematosus treated with intravenous immunoglobulin.

Authors:  Guida Santos; Alexandre João; Lourdes Sousa
Journal:  J Dermatol Case Rep       Date:  2014-06-30

2.  [Painful recurrent leg ulcers].

Authors:  I Bertlich; A Enk; F Toberer
Journal:  Hautarzt       Date:  2018-09       Impact factor: 0.751

3.  [Primary antiphospholipid syndrome: newly developed leg ulcer and history of stroke].

Authors:  N Van Beek; N Schumacher; O Haase; D Zillikens; B Kahle; E Schmidt
Journal:  Hautarzt       Date:  2013-09       Impact factor: 0.751

4.  Antiphospholipid Antibodies in Sickle Cell Disease: A Systematic Review and Exploratory Meta-Analysis.

Authors:  Mira Merashli; Alessia Arcaro; Maria Graf; Matilde Caruso; Paul R J Ames; Fabrizio Gentile
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

5.  An atypical presentation of antiphospholipid antibody syndrome.

Authors:  Deepti D'souza; Sukumar Dandakeri; M Ramesh Bhat; M K Srinath
Journal:  Indian Dermatol Online J       Date:  2015 Jul-Aug

6.  Two case reports of pyoderma gangrenosum and systemic lupus erythematosus: A rare but nonfortuitous association?

Authors:  Delphine Lebrun; Ailsa Robbins; Maxime Hentzien; Ségolène Toquet; Julie Plee; Anne Durlach; Jean-David Bouaziz; Firouzé Bani-Sadr; Amélie Servettaz
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.